Item 4. Controls and Procedures
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation
of our management, including our Chief Executive Officer and our Chief Financial Officer (together, the “Certifying Officers”),
as of June 30, 2021, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures
as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. In connection with this Report, our Certifying Officers reevaluated
and concluded that our disclosure controls and procedures were not effective, due solely to the material weakness in our internal control
over financial reporting as it specifically relates to the significant change in the accounting treatment of our warrants and FPS and
described in our March 31, 2021 Quarterly Report on Form 10-Q. In light of this material weakness, we performed additional analyses as
deemed necessary to ensure that our financial statements were prepared in accordance with U.S. generally accepted accounting principles.
Notwithstanding the identified material weakness as of June 30, 2021, management believes that the financial statements included in this
Report present fairly in all material respects our financial position, results of operations and cash flows for the period presented.
Disclosure controls and procedures are controls
and other procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange
Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls
and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our
reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Certifying Officers, or
persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial
Reporting
There was no change in our internal control over
financial reporting that occurred during the fiscal quarter ended June 30, 2021 covered by this Quarterly Report on Form 10-Q that has
materially affected, or is reasonably likely to materially affect, our internal control over financial reporting, with the exception of
the below.
While we have processes to identify and appropriately
apply applicable accounting requirements, we have enhanced our system of evaluating and implementing the accounting standards that apply
to our financial statements, including through enhanced analyses by our personnel and third-party professionals with whom we consult regarding
complex accounting applications. Specifically, during 2021 and through the date of this filing, management has been focused on remediating
the material weakness in our internal control over financial reporting. Management believes the measures that we have implemented during
2021 have had a favorable impact on our internal control over financial reporting.
As part of our remediation efforts in connection
with the identification of the material weakness discussed above, we have taken the following steps during the six months ended June 30,
2021:
● We have implemented procedures intended to ensure
that we identify and apply the applicable accounting guidance to all complex transactions.
● We are establishing additional monitoring and
oversight controls designed to ensure the accuracy and completeness of our condensed financial statements and related disclosures.
● During 2021, management performed a broad and
detailed analysis over the classification of our warrant and FPS liabilities. Based on the analysis, the warrants and FPS are classified
as liabilities on our condensed balance sheet and measured at fair value through condensed statement of operations at the end of each
reporting period.
While we took considerable action to remediate
the material weakness, such remediation has not been fully evidenced. Accordingly, we continue to test our controls implemented during
the six months ended June 30, 2021 to assess whether our controls are operating effectively. While there can be no assurance, we believe
our material weakness will be remediated during the course of fiscal 2021.
24
PART
II – OTHER INFORMATION
Item 1.
Legal Proceedings
None.
Item 1A.
Risk Factors.
There
have been no material changes from the risk factors previously disclosed in the Company’s most recent prospectus for the Initial
Public Offering as filed with the SEC on March 15, 2021 and the Company’s Form 10-Q for the quarter ended March 31, 2021
as filed with the SEC on May 17, 2021 .
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.